<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><description>The JCI is a premiere venue for discoveries in basic and clinical biomedical science that will advance the practice of medicine. Est. 1924</description><link>https://bsky.app/profile/jci.org</link><title>@jci.org - Journal of Clinical Investigation</title><item><link>https://bsky.app/profile/jci.org/post/3muub4gwp3h2o</link><description>ICYMI: Robert A. Koeth &amp; team report on a link between diet, the #GutMicrobiome and #AFib: https://doi.org/10.1172/JCI201684&#xA;✅ Integration of a large clinical dataset (&gt;5000)&#xA;✅ Rigorous animal modeling&#xA;✅ Thorough metagenomics</description><pubDate>06 Sep 2026 15:00 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3muub4gwp3h2o</guid></item><item><link>https://bsky.app/profile/jci.org/post/3museqnw5n72l</link><description>Saturday Highlight💫: How might we muscle through #sarcopenia as we age? https://doi.org/10.1172/JCI190646&#xA;W. David Arnold &amp; team explored muscle function in aged rodents, identifying NMJ deficits and a potential therapeutic strategy to improve muscle function in #aging.&#xA;@tomgillingwater.bsky.social</description><pubDate>05 Sep 2026 21:00 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3museqnw5n72l</guid></item><item><link>https://bsky.app/profile/jci.org/post/3mupueg7mpi2h</link><description>Alpha-Gal syndrome is a tick bite-associated allergy characterized by reactions to alpha-Gal found in red meat&#xA;&#xA;https://doi.org/10.1172/JCI192370&#xA;Peter D. Crompton &amp; team show the potential of alpha-Gal-specific mAbs to prevent the allergy by blocking IgE binding to alpha-Gal.&#xA;@the-asci.org</description><pubDate>04 Sep 2026 21:02 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3mupueg7mpi2h</guid></item><item><link>https://bsky.app/profile/jci.org/post/3munduiq27f26</link><description>Genetic mapping of monocyte fate decisions following myocardial infarction: https://doi.org/10.1172/JCI209791&#xA;&#xA;Sakalli et al. provide a Commentary on Koenig et al.: https://doi.org/10.1172/JCI189684</description><pubDate>03 Sep 2026 21:01 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3munduiq27f26</guid></item><item><link>https://bsky.app/profile/jci.org/post/3mumptlbr2v2t</link><description>Early signals shape cardiac macrophage phenotypes &amp; repair outcomes: https://doi.org/10.1172/JCI189684&#xA;Kory J Lavine &amp; team traced monocyte differentiation trajectories after injury &amp; identified an MHCIIhi population with an early IFN response signature associated with enhanced cardioprotection&#xA;@the-asci.org</description><pubDate>03 Sep 2026 15:03 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3mumptlbr2v2t</guid></item><item><link>https://bsky.app/profile/jci.org/post/3muktfpck732m</link><description>Fueling fibrosis: BCAT1 links branched-chain amino acid metabolism to collagen production: https://doi.org/10.1172/JCI209543&#xA;&#xA;Marco Ronfini &amp; John W. Elrod comment on Takizawa et al.: https://doi.org/10.1172/JCI182216&#xA;#Fibrosis</description><pubDate>02 Sep 2026 21:01 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3muktfpck732m</guid></item><item><link>https://bsky.app/profile/jci.org/post/3mukdfhbodu2k</link><description>BCAT1 provides building blocks for cardiac fibrogenesis: https://doi.org/10.1172/JCI182216 &#xA;Michio Nakaya &amp; team reveal how activated cardiac fibroblasts meet the high demand for proline in collagen synthesis. The image shows Bcat1 and Col1a1 mRNA expression in the infarcted mouse heart. &#xA;#CardiacFibrosis</description><pubDate>02 Sep 2026 16:15 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3mukdfhbodu2k</guid></item><item><link>https://bsky.app/profile/jci.org/post/3muk7dlcujl2s</link><description>How might we muscle through sarcopenia as we age? https://doi.org/10.1172/JCI190646&#xA;&#xA;W. David Arnold &amp; team explored muscle function in aged rodents, identifying neuromuscular junction deficits and a potential therapeutic strategy to improve muscle function in aging.&#xA;@tomgillingwater.bsky.social</description><pubDate>02 Sep 2026 15:02 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3muk7dlcujl2s</guid></item><item><link>https://bsky.app/profile/jci.org/post/3muicw65ed52x</link><description>Robert A. Koeth &amp; team report on a link between diet, the #GutMicrobiome and #AtrialFibrillation: https://doi.org/10.1172/JCI201684&#xA;✅ Integration of a large clinical dataset (&gt;5000)&#xA;✅ Rigorous animal modeling&#xA;✅ Thorough metagenomics</description><pubDate>01 Sep 2026 21:01 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3muicw65ed52x</guid></item><item><link>https://bsky.app/profile/jci.org/post/3muhswrducu2m</link><description>The multiple faces of γδ T cells in cancer&#xA;This issue’s cover: Bolini et al reviews the complex biology of γδT cells &amp; describe current attempts to harness the cell type for cancer therapy.&#xA;A unique T cell subset can restrain or support cancer progression: https://doi.org/10.1172/JCI209159&#xA;Photo by L Galluzzi</description><pubDate>01 Sep 2026 16:15 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3muhswrducu2m</guid></item><item><link>https://bsky.app/profile/jci.org/post/3muf6h4b4ot2d</link><description>Do the math: modernizing the FDA’s evidence paradigm for precision medicine: https://doi.org/10.1172/JCI211143&#xA;&#xA;In this Viewpoint, Peter J. Pitts @peterpitts.bsky.social et al. discuss “dominator collapse” as a reality for modern drug development&#xA;#FutureOfMedicine #RareDisease</description><pubDate>31 Aug 2026 15:03 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3muf6h4b4ot2d</guid></item><item><link>https://bsky.app/profile/jci.org/post/3mucnvm6n6v2m</link><description>Weekend spotlight💫: Reproductive life after In vitro fertilization: https://doi.org/10.1172/JCI210577&#xA;JCI Associate Editor Serdar E. Bulun discusses what the observations in mouse models from Rhon-Calderon et al. (https://doi.org/10.1172/JCI201633) might mean for human offspring born with #IVF assistance.</description><pubDate>30 Aug 2026 15:01 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3mucnvm6n6v2m</guid></item><item><link>https://bsky.app/profile/jci.org/post/3mu7woost4c2m</link><description>Worth another look💫: This study describes a promising therapeutic strategy for advanced prostate cancer: https://doi.org/10.1172/JCI203835&#xA;&#xA;Karen Cichowski &amp; team find a combo treatment (that suppresses epigenetic and oncogenic enzymes), can trigger metabolic collapse of tumors in CRPC models.</description><pubDate>29 Aug 2026 13:01 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3mu7woost4c2m</guid></item><item><link>https://bsky.app/profile/jci.org/post/3mu5mz7arzj2i</link><description>A dual mechanism for immunosuppression in pancreatic cancer: https://doi.org/10.1172/JCI197733&#xA;&#xA;Hussain et al. find extracellular vesicles produced by pancreatic tumor cells modulate non-tumoral cells behavior (involving ALOX15b+ macrophages and SFRP1+ CAFs) to foster an immunosuppressive ecosystem.</description><pubDate>28 Aug 2026 15:02 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3mu5mz7arzj2i</guid></item><item><link>https://bsky.app/profile/jci.org/post/3mu34kcp3dh2i</link><description>Uncovering the backbone of disc degeneration&#xA;&#xA;Cao Yang &amp; team discover PRMT2 deficiency‒mediated methylation-ubiquitination crosstalk of MED12 promotes R-loop/cGAS/STING axis-dependent progression of Intervertebral disc degeneration: https://doi.org/10.1172/JCI197274&#xA;#IVDD #BackPain</description><pubDate>27 Aug 2026 15:02 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3mu34kcp3dh2i</guid></item><item><link>https://bsky.app/profile/jci.org/post/3mtza5gx7h52i</link><description>Reproductive life after In vitro fertilization: https://doi.org/10.1172/JCI210577&#xA;&#xA;JCI Editor Serdar E. Bulun discusses what the observations in mouse models from Rhon-Calderon et al. (https://doi.org/10.1172/JCI201633) might mean for human offspring born with IVF assistance&#xA;@the-asci.org</description><pubDate>26 Aug 2026 21:01 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3mtza5gx7h52i</guid></item><item><link>https://bsky.app/profile/jci.org/post/3mtw3mupg4s24</link><description>Early ovarian failure in IVF-conceived mice https://doi.org/10.1172/JCI201633&#xA;&#xA;Marisa S. Bartolomei &amp; team report signs of accelerated reproductive aging in female mice conceived via in vitro fertilization, leading to reduced fertility in this model.</description><pubDate>25 Aug 2026 15:02 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3mtw3mupg4s24</guid></item><item><link>https://bsky.app/profile/jci.org/post/3mtu76db3hi24</link><description>This study describes a promising therapeutic strategy for advanced prostate cancer: https://doi.org/10.1172/JCI203835&#xA;&#xA;Karen Cichowski &amp; team find a combo treatment (that suppresses epigenetic and oncogenic enzymes), can trigger metabolic collapse of tumors in CRPC models.</description><pubDate>24 Aug 2026 21:01 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3mtu76db3hi24</guid></item><item><link>https://bsky.app/profile/jci.org/post/3mttl5fe47j2z</link><description>Targeting the gut microbiome may improve heart transplant outcomes: https://doi.org/10.1172/JCI207999&#xA;In this Review, Ivan Ðuran, W. H. Wilson Tang, &amp; Petra Mamic describe the microbiome as a modifiable risk factor in heart failure and heart transplant.</description><pubDate>24 Aug 2026 15:02 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3mttl5fe47j2z</guid></item><item><link>https://bsky.app/profile/jci.org/post/3mtr2lwcmkg24</link><description>Weekend read💫: Featured on this issue’s cover, Hao et al. report PTEN deficiency enhances sensitivity to ATR inhibition in preclinical models and clinical trials of high-grade serous ovarian cancer: https://doi.org/10.1172/JCI197645&#xA;Image credit: David A. Litman/Shutterstock</description><pubDate>23 Aug 2026 15:01 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3mtr2lwcmkg24</guid></item><item><link>https://bsky.app/profile/jci.org/post/3mtodgdkgqd2z</link><description>Saturday spotlight💫 : Combining radiotherapy with immunotherapy to improve cancer treatment: https://doi.org/10.1172/JCI207550&#xA;In this Review, Lu Lu &amp; Liufu Deng describe the rationale behind using radiotherapy to enhance the response to #cancer #immunotherapy.</description><pubDate>22 Aug 2026 13:01 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3mtodgdkgqd2z</guid></item><item><link>https://bsky.app/profile/jci.org/post/3mtmnsmvwux2j</link><description>Monoclonal antibody CIS43LS sets the bar for long-acting malaria protection: https://doi.org/10.1172/JCI209790&#xA;&#xA;David J. Sullivan @johnshopkinssph.bsky.social provides a Commentary on Tran et al.: https://doi.org/10.1172/JCI207559</description><pubDate>21 Aug 2026 21:01 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3mtmnsmvwux2j</guid></item><item><link>https://bsky.app/profile/jci.org/post/3mtlzr4lef42b</link><description>Anti-malaria mAb demonstrates durable protection in African adults https://doi.org/10.1172/JCI207559 &#xA;&#xA;Peter D. Crompton &amp; team assessed the phase II trial of CIS43LS, revealing that the long-acting mAb maintained over 80% protection through a single malaria season.  &#xA;@mmv.org&#xA;@the-asci.org</description><pubDate>21 Aug 2026 15:02 +0000</pubDate><guid isPermaLink="false">at://did:plc:dp6fotbhabsloue6hd2bec2s/app.bsky.feed.post/3mtlzr4lef42b</guid></item></channel></rss>